1996
DOI: 10.1074/jbc.271.13.7602
|View full text |Cite
|
Sign up to set email alerts
|

The Domain Organization of Human Topoisomerase I

Abstract: Using limited proteolysis, we show that the domain boundaries of human topoisomerase I closely parallel those predicted from sequence comparisons with other cellular Topo I enzymes. The enzyme is comprised of (i) an NH 2 -terminal domain (ϳ24 kDa), which is known to be dispensable for activity, (ii) the core domain (ϳ54 kDa), (iii) a linker region (ϳ3 kDa), and (iv) the COOHterminal domain (ϳ10 kDa), which contains the active site tyrosine. The highly conserved core and COOH-terminal domains are resistant to p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

7
156
0
1

Year Published

1999
1999
2010
2010

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 162 publications
(164 citation statements)
references
References 34 publications
(37 reference statements)
7
156
0
1
Order By: Relevance
“…The QuikChange site-directed mutagenesis kit from Stratagene was used to introduce the A499C and H367C mutations into pFASTBAC-topo70. The recombinant baculovirus expressing the resulting topo70 2XCys protein was generated with the Bac-to-Bac expression system according to the protocol provided by the manufacturer (Invitrogen), and the double mutant protein was purified from baculovirus-infected cells as described for WT topo70 (12). Briefly, the purification procedure involved fractionation on phosphocellulose, followed by Mono Q (5H͞R) and Mono S (5H͞R) chromatography by using the FPLC system from Amersham Pharmacia Biotech.…”
Section: Methodsmentioning
confidence: 99%
“…The QuikChange site-directed mutagenesis kit from Stratagene was used to introduce the A499C and H367C mutations into pFASTBAC-topo70. The recombinant baculovirus expressing the resulting topo70 2XCys protein was generated with the Bac-to-Bac expression system according to the protocol provided by the manufacturer (Invitrogen), and the double mutant protein was purified from baculovirus-infected cells as described for WT topo70 (12). Briefly, the purification procedure involved fractionation on phosphocellulose, followed by Mono Q (5H͞R) and Mono S (5H͞R) chromatography by using the FPLC system from Amersham Pharmacia Biotech.…”
Section: Methodsmentioning
confidence: 99%
“…Human topoisomerase I breaks one strand of duplex DNA and relaxes superhelical tension by a postulated ''controlled rotation'' mechanism (6). The 765-aa enzyme is composed of four major regions: a highly charged and putatively unstructured N-terminal domain (residues 1-200; removed for structural studies), a conserved core domain (residues 201-635), a flexible linker domain (residues 636-712), and a conserved C-terminal domain (residues 713-765) that contains the catalytic Tyr-723 residue (7). Several crystal structures of human topoisomerase I in both covalent and noncovalent complexes with DNA have been reported (6,(8)(9)(10).…”
mentioning
confidence: 99%
“…This is unlikely to be in terms of catalytic efficiency. Separation of the core and catalytic domains of human topoisomerase IB by proteolytic cleavage within the unconserved linker does not markedly affect catalysis (32). Separate domains may permit the subunits to function independently, perhaps in conjunction with other partners (a possibility that we should explore with RNA interference studies).…”
Section: Discussionmentioning
confidence: 99%